Not checked for notices yet.
Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma
James J. Harding, Richard K. Do, Amin Yaqubie and 7 more
Cancer Medicine · 2021
Cited by papers we hold 4
- Hepatocellular carcinoma: signaling pathways and therapeutic advances · 2025No notice
- Targeting cytokine and chemokine signaling pathways for cancer therapy · 2024No notice
- TGF-beta signal transduction: biology, function and therapy for diseases · 2022No notice
- Targeting the tumor stroma for cancer therapy · 2022No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.